Dow Down 0.62% Nasdaq Up 0.35%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
6.45 Down 0.53(7.59%) 4:00PM EST
|After Hours : 6.46 Up 0.01 (0.16%) 4:27PM EST - Nasdaq Real Time Price
Prev Close:6.98
Open:7.06
Bid:6.40 x 200
Ask:6.46 x 2900
1y Target Est:34.00
Beta:3.52636
Earnings Date:Feb 22 - Feb 26 (Est.)
Day's Range:6.43 - 7.25
52wk Range:6.43 - 32.82
Volume:4,169,983
Avg Vol (3m):2,449,200
Market Cap:636.27M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXDown 7.59%636.27M
LLYDown 0.22%77.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):133.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.32
Quarterly EPS Est (Dec-15) :-0.35
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback